Global Coartem (Artemether/Lumefantrine) Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Coartem (Artemether/Lumefantrine) market report explains the definition, types, applications, major countries, and major players of the Coartem (Artemether/Lumefantrine) market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Kerui Nanhai Pharmaceutical

    • Novartis

    • Guilin Pharmaceutical CO LTD

    • Sanofi-Aventis

    • KPC Pharmaceuticals Inc

    • Kunming Pharmaceutical

    • Guangxi Xiancaotang Pharmaceutical CO LTD

    By Type:

    • Artemether

    • Lumefantrine

    By End-User:

    • Hospital Pharmacy

    • Retail Pharmacy

    • Online Pharmacy

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Coartem (Artemether/Lumefantrine) Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Coartem (Artemether/Lumefantrine) Outlook to 2028- Original Forecasts

    • 2.2 Coartem (Artemether/Lumefantrine) Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Coartem (Artemether/Lumefantrine) Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Coartem (Artemether/Lumefantrine) Market- Recent Developments

    • 6.1 Coartem (Artemether/Lumefantrine) Market News and Developments

    • 6.2 Coartem (Artemether/Lumefantrine) Market Deals Landscape

    7 Coartem (Artemether/Lumefantrine) Raw Materials and Cost Structure Analysis

    • 7.1 Coartem (Artemether/Lumefantrine) Key Raw Materials

    • 7.2 Coartem (Artemether/Lumefantrine) Price Trend of Key Raw Materials

    • 7.3 Coartem (Artemether/Lumefantrine) Key Suppliers of Raw Materials

    • 7.4 Coartem (Artemether/Lumefantrine) Market Concentration Rate of Raw Materials

    • 7.5 Coartem (Artemether/Lumefantrine) Cost Structure Analysis

      • 7.5.1 Coartem (Artemether/Lumefantrine) Raw Materials Analysis

      • 7.5.2 Coartem (Artemether/Lumefantrine) Labor Cost Analysis

      • 7.5.3 Coartem (Artemether/Lumefantrine) Manufacturing Expenses Analysis

    8 Global Coartem (Artemether/Lumefantrine) Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Coartem (Artemether/Lumefantrine) Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Coartem (Artemether/Lumefantrine) Export by Region (Top 10 Countries) (2017-2028)

    9 Global Coartem (Artemether/Lumefantrine) Market Outlook by Types and Applications to 2022

    • 9.1 Global Coartem (Artemether/Lumefantrine) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Artemether Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Lumefantrine Consumption and Growth Rate (2017-2022)

    • 9.2 Global Coartem (Artemether/Lumefantrine) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Coartem (Artemether/Lumefantrine) Market Analysis and Outlook till 2022

    • 10.1 Global Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.2.2 Canada Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.2.3 Mexico Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.2 UK Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.3 Spain Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.4 Belgium Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.5 France Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.6 Italy Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.7 Denmark Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.8 Finland Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.9 Norway Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.10 Sweden Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.11 Poland Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.12 Russia Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.3.13 Turkey Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.2 Japan Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.3 India Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.4 South Korea Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.5 Pakistan Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.6 Bangladesh Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.7 Indonesia Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.8 Thailand Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.9 Singapore Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.10 Malaysia Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.11 Philippines Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.4.12 Vietnam Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.2 Colombia Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.3 Chile Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.4 Argentina Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.5 Venezuela Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.6 Peru Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.7 Puerto Rico Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.5.8 Ecuador Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.6.2 Kuwait Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.6.3 Oman Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.6.4 Qatar Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.7.2 South Africa Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.7.3 Egypt Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.7.4 Algeria Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

      • 10.8.2 New Zealand Coartem (Artemether/Lumefantrine) Consumption (2017-2022)

    11 Global Coartem (Artemether/Lumefantrine) Competitive Analysis

    • 11.1 Kerui Nanhai Pharmaceutical

      • 11.1.1 Kerui Nanhai Pharmaceutical Company Details

      • 11.1.2 Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.1.4 Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Novartis

      • 11.2.1 Novartis Company Details

      • 11.2.2 Novartis Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Novartis Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.2.4 Novartis Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Guilin Pharmaceutical CO LTD

      • 11.3.1 Guilin Pharmaceutical CO LTD Company Details

      • 11.3.2 Guilin Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Guilin Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.3.4 Guilin Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Sanofi-Aventis

      • 11.4.1 Sanofi-Aventis Company Details

      • 11.4.2 Sanofi-Aventis Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Sanofi-Aventis Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.4.4 Sanofi-Aventis Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 KPC Pharmaceuticals Inc

      • 11.5.1 KPC Pharmaceuticals Inc Company Details

      • 11.5.2 KPC Pharmaceuticals Inc Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 KPC Pharmaceuticals Inc Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.5.4 KPC Pharmaceuticals Inc Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Kunming Pharmaceutical

      • 11.6.1 Kunming Pharmaceutical Company Details

      • 11.6.2 Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.6.4 Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Guangxi Xiancaotang Pharmaceutical CO LTD

      • 11.7.1 Guangxi Xiancaotang Pharmaceutical CO LTD Company Details

      • 11.7.2 Guangxi Xiancaotang Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Guangxi Xiancaotang Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Main Business and Markets Served

      • 11.7.4 Guangxi Xiancaotang Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    12 Global Coartem (Artemether/Lumefantrine) Market Outlook by Types and Applications to 2028

    • 12.1 Global Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Artemether Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Lumefantrine Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Coartem (Artemether/Lumefantrine) Market Analysis and Outlook to 2028

    • 13.1 Global Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.2.2 Canada Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.2 UK Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.3 Spain Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.5 France Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.6 Italy Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.8 Finland Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.9 Norway Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.11 Poland Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.12 Russia Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.2 Japan Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.3 India Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.3 Chile Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.6 Peru Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.6.3 Oman Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Coartem (Artemether/Lumefantrine) Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Coartem (Artemether/Lumefantrine)

    • Figure of Coartem (Artemether/Lumefantrine) Picture

    • Table Global Coartem (Artemether/Lumefantrine) Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Coartem (Artemether/Lumefantrine) Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Artemether Consumption and Growth Rate (2017-2022)

    • Figure Global Lumefantrine Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Retail Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Table North America Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure United States Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Canada Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Mexico Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table Europe Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure Germany Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure UK Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Spain Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Belgium Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure France Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Italy Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Denmark Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Finland Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Norway Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Sweden Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Poland Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Russia Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Turkey Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table APAC Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure China Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Japan Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure India Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Thailand Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Singapore Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Philippines Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table South America Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure Brazil Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Colombia Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Chile Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Argentina Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Peru Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table GCC Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure Bahrain Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Oman Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Qatar Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table Africa Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure Nigeria Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure South Africa Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Egypt Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure Algeria Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table Oceania Coartem (Artemether/Lumefantrine) Consumption by Country (2017-2022)

    • Figure Australia Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Coartem (Artemether/Lumefantrine) Consumption and Growth Rate (2017-2022)

    • Table Kerui Nanhai Pharmaceutical Company Details

    • Table Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table Novartis Coartem (Artemether/Lumefantrine) Product Portfolio

    • Table Guilin Pharmaceutical CO LTD Company Details

    • Table Guilin Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guilin Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table Guilin Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Product Portfolio

    • Table Sanofi-Aventis Company Details

    • Table Sanofi-Aventis Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi-Aventis Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table Sanofi-Aventis Coartem (Artemether/Lumefantrine) Product Portfolio

    • Table KPC Pharmaceuticals Inc Company Details

    • Table KPC Pharmaceuticals Inc Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table KPC Pharmaceuticals Inc Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table KPC Pharmaceuticals Inc Coartem (Artemether/Lumefantrine) Product Portfolio

    • Table Kunming Pharmaceutical Company Details

    • Table Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Product Portfolio

    • Table Guangxi Xiancaotang Pharmaceutical CO LTD Company Details

    • Table Guangxi Xiancaotang Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Guangxi Xiancaotang Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Main Business and Markets Served

    • Table Guangxi Xiancaotang Pharmaceutical CO LTD Coartem (Artemether/Lumefantrine) Product Portfolio

    • Figure Global Artemether Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lumefantrine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Retail Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Table North America Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure United States Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure Germany Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure China Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure Brazil Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Coartem (Artemether/Lumefantrine) Consumption Forecast by Country (2022-2028)

    • Figure Australia Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Coartem (Artemether/Lumefantrine) Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.